Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Vaccine Efficacy
83%
Spike
53%
Receptor Binding
36%
Neutralizing Antibody
36%
Virus-Like Particle
34%
Antibody Response
33%
Virus Like Particle Vaccine
33%
Capsid
33%
Virus Neutralization
33%
Baculoviridae
13%
Mouse
11%
Insect Cell
10%
Neutralization
9%
Escherichia coli
9%
COVID-19
8%
Gene Expression System
7%
Vaccination Policy
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Virus Like Agent
42%
Receptor
38%
Infection
36%
Neutralizing Antibody
36%
Virus Like Particle Vaccine
33%
Nanoparticle
33%
Baculoviridae
19%
Mouse
15%
Escherichia coli
11%
Adenovirus Vector
9%
Protein-Based Vaccine
9%
Vaccination Policy
7%
Parasitosis
5%
Preclinical Study
5%
Influenza
5%
Immunogenicity
5%
Antigen
5%
Protein Variant
5%
Disease Marker
5%
Coronavirinae
5%
Clinical Trial
5%
Guanosine Phosphate
5%
Virus Infection
5%
Disease
5%